Wuersch & Gering Represents Novabiosis, Inc. in its Acquisition of the Assets of Promethera Therabpeutic, SA

Written By Mark Istvan Ledeczi-Domonkos

October 6, 2021 - Wuersch & Gering represented Novabiosis, Inc. in its acquisition of the assets of Promethera Therabpeutic, SA’s  human cell and tissue-based research products business.

Wuersch & Gering’s team included Marco Palmese (M&A), Erik Tikannen (Corporate) and Orla McCabe (Employment).

Mark Istvan Ledeczi-Domonkos
Previous

Wuersch & Gering Represents Bionique Testing Laboratories in its Sale to Asahi Kasei Medical Co., Ltd.
Next

Wuersch & Gering Represents Verder Group in its Acquisition of Mager Scientific, Inc.